{"filing":{"accession_number":"0001636422-26-000111","cik":"0001636422","ticker":"HCAT","company_name":"Health Catalyst, Inc.","form":"8-K","filing_date":"2026-09-14","report_date":"2026-09-11","primary_document":"hcat-20260911.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1636422/000163642226000111/hcat-20260911.htm"},"events":[{"id":33301,"run_id":30614,"accession_number":"0001636422-26-000111","anchor_item_number":"5.02","event_type":"exec_appointment","event_domain":"governance","is_material":true,"confidence":0.95,"summary":"Tami Reller was appointed to Health Catalyst's Board of Directors effective October 1, 2026, filling a newly created seat as the Board expanded from six to seven directors. She was also appointed as Audit Committee Chair and member of the Compensation Committee.","company_name":"Health Catalyst, Inc.","ticker":"HCAT","filing_date":"2026-09-14","form":"8-K","submitted_at":null,"items":[{"id":36709,"accession_number":"0001636422-26-000111","item_number":"5.02","item_title":"Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.","event_type":"exec_appointment","event_domain":"governance","is_material":true,"confidence":0.95,"reasoning":"Tami Reller was appointed to Health Catalyst's Board of Directors effective October 1, 2026, filling a newly created seat as the Board expanded from six to seven directors. She was also appointed as Audit Committee Chair and member of the Compensation Committee. This is a clear director appointment with significant governance responsibilities, making it a material executive appointment event.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-09-14T20:25:59.836712+00:00","company_name":"","ticker":null,"filing_date":""},{"id":36710,"accession_number":"0001636422-26-000111","item_number":"7.01","item_title":"Regulation FD Disclosure.","event_type":"exec_appointment","event_domain":"governance","is_material":true,"confidence":0.95,"reasoning":"The filing discloses the appointment of Tami Reller to Health Catalyst's board of directors, effective October 1, 2026, with roles as audit chair and compensation committee member. This is a material governance event involving the appointment of a named executive/director with significant public-company board experience and specialized expertise in healthcare and technology. The press release emphasizes her qualifications and strategic importance to the company's next phase of growth.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-09-14T20:25:59.836712+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":36709,"accession_number":"0001636422-26-000111","item_number":"5.02","item_title":"Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.","event_type":"exec_appointment","event_domain":"governance","is_material":true,"confidence":0.95,"reasoning":"Tami Reller was appointed to Health Catalyst's Board of Directors effective October 1, 2026, filling a newly created seat as the Board expanded from six to seven directors. She was also appointed as Audit Committee Chair and member of the Compensation Committee. This is a clear director appointment with significant governance responsibilities, making it a material executive appointment event.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-09-14T20:25:59.836712+00:00","company_name":"Health Catalyst, Inc.","ticker":"HCAT","filing_date":"2026-09-14"},{"id":36710,"accession_number":"0001636422-26-000111","item_number":"7.01","item_title":"Regulation FD Disclosure.","event_type":"exec_appointment","event_domain":"governance","is_material":true,"confidence":0.95,"reasoning":"The filing discloses the appointment of Tami Reller to Health Catalyst's board of directors, effective October 1, 2026, with roles as audit chair and compensation committee member. This is a material governance event involving the appointment of a named executive/director with significant public-company board experience and specialized expertise in healthcare and technology. The press release emphasizes her qualifications and strategic importance to the company's next phase of growth.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-09-14T20:25:59.836712+00:00","company_name":"Health Catalyst, Inc.","ticker":"HCAT","filing_date":"2026-09-14"}]}